Roswell Park Cancer Institute will provide clinical consultations and training for staff at Lakeshore Cancer Center, Lagos, Nigeria, through an affiliation announced today.
30-Jun-2015 1:05 PM EDT
Early Menarche May Be Important in Development of Aggressive Breast Cancer in African-American Women
Early age at menarche, or first menstrual cycle, could play a role in the disproportionate incidence of estrogen receptor (ER)-negative breast cancers diagnosed among African-American women, according to a study published in the Journal of the...
17-Jun-2015 3:00 PM EDT
Roswell Park Photodynamic Therapy Center Receives $10M Federal Award to Optimize Head & Neck Cancer Treatments
Roswell Park will receive a five-year, $10 million NCI award to continue its PDT research program in head and neck cancers and conduct clinical trials in collaboration with other centers.
16-Jun-2015 2:05 PM EDT
OmniSeq, LLC has officially begun its spin-out from Roswell Park Cancer Institute and will immediately begin commercializing its suite of innovative products that match cancer patients to therapies tailored specifically to them.
11-Jun-2015 8:45 AM EDT
Blood and Marrow Transplantation (BMT) is a potentially curative treatment for patients with leukemia or other life-threating blood diseases. With a goal of increasing survival rates, a research team led by Roswell Park Cancer Institute (RPCI)...
9-Jun-2015 4:00 PM EDT
Phase III Study Confirms Benefits of Lenalidomide Maintenance Therapy for Patients with Multiple Myeloma
A large cooperative-group study has confirmed previous evidence that lenalidomide delays time to disease progression for patients with multiple myeloma and is an important treatment option for patients with the disease.
31-May-2015 7:00 AM EDT
A multiplatform biomarker analysis of squamous cell anal carcinoma samples led by Roswell Park in conjunction with Caris Life Sciences has revealed several actionable targets.
29-May-2015 1:00 PM EDT
A collaborative team of researchers led by Alex A. Adjei, MD, PhD, FACP, of Roswell Park Cancer Institute (RPCI) will share results from the first clinical study of the anticancer effects of the novel agent entolimod at the American Society of...
28-May-2015 4:00 PM EDT
Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT